Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. (Q50558265)
Jump to navigation
Jump to search
scientific article published on 5 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. |
scientific article published on 5 November 2010 |
Statements
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease (English)
John Boletis
Fatih Besisik
Maria Lúcia Ferraz
Laurent Alric
Diethelm Messinger
Andreas Tietz